References

1. Mackowiak PA. Concepts of fever. Arch Intern Med. 1998;158(17):1870–81. 

2. Kluger MJ. Phylogeny of fever. In: Federation Proceedings [Internet]. 1979 [zitiert 15. Februar 2016]. S. 30–34.http://europepmc.org/abstract/med/759235

3. Blatteis CM. Fever: is it beneficial? Yale J Biol Med. 1986;59(2):107–16. 

4. Bernheim HA, Kluger MJ. Fever: effect of drug-induced antipyresis on survival. Science. 16. Juli 1976;193(4249):237–9. 

5. Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analyis. J R Soc Med. 1. Oktober 2010;103(10):403–11. 

6. Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetaminophen: more harm than good for chickenpox? J Pediatr. Juni 1989;114(6):1045–8. 

7. Brandts CH, Ndjave M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. 1997;350(9079):704–9. 

8. Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Li P, u. a. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect. 2005;6(4):369–75. 

9. Mackowiak PA. Direct effects of hyperthermia on pathogenic microorganisms: Teleologic implications with regard to fever. Rev Infect Dis. 1. Januar 1980;3(3):508–20. 

10. Mackowiak PA, Marling C. Hyperthermic enhancement of serum antimicrobial activity: mechanism by which fever might exert a beneficial effect on the outcome of gram-negative sepsis. Infect Immun. Januar 1983;39(1):38–42. 

11. Appenheimer MM, Chen Q, Girard RA, Wang WC, Evans SS. Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking. Immunol Invest. 2005;34(3):295–323. 

12. Plaisance KI, Kudaravalli S, Wasserman SS, Levine MM, Mackowiak PA. Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections. Pharmacotherapy. Dezember 2000;20(12):1417–22. 

13. Roberts NJ. Temperature and host defense. Microbiol Rev. Juni 1979;43(2):241–59. 

14. Bryant RE, Hood AF, Hood CE, Koenig MG. Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med. Januar 1971;127(1):120–8. 

15. Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J. März 1997;90(3):296–8. 

16. El-Radhi ASM. Why is the evidence not affecting the practice of fever management? Arch Dis Child. November 2008;93(11):918–20. 

17. Sullivan JE, Farrar HC, American Academy of Pediatrics, the Section on Clinical Pharmacology and Therapeutics. Clinical Report--Fever and Antipyretic Use in Children. Pediatrics. 28. Februar 2011;peds.2010-3852. 

18. Anthromedics - Rhinosinusitis: Anthroposophic approach to acute and recurrent rhinosinusitis in adults and children [Internet]. [zitiert 13. März 2019]. : https://www.anthromedics.org/PRA-0685-EN#citation10

19. Sund‐Levander M, Forsberg C, Wahren LK. Normal oral, rectal, tympanic and axillary body temperature in adult men and women: a systematic literature review. Scand J Caring Sci. 2002;16(2):122–8. 

20. Mackowiak PA, Wasserman SS, Levine MM. A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA. 23. September 1992;268(12):1578–80. 

21. Ministry of Public Health, General Directorate of Pharmaceutical Affairs. National Standard Treatment Guidelines for the Primary Level [Internet]. 2013. : http://apps.who.int/medicinedocs/documents/s21744en/s21744en.pdf

22. L’association des pédiatres libéraux d’Alger (APLA). Fièvre de l’enfant: que faire? [Internet]. apla. [zitiert 23. Mai 2018]. : http://www.apla-dz.org/conseils-aux-parents/maladies-infantiles/votre-en...

23. South Australian  Child Health Clinical Network. Management of Fever without Focus in Children (excluding neonates), Clinical Guideline [Internet]. 2013. : http://www.sahealth.sa.gov.au/wps/wcm/connect/812ad70040d041b4972cbf40b8...

24. Österreichische Gesellschaft für Kinder- und Jugendheilkunde. Fieber und Schmerzen: Was tun? [Internet]. : http://www.paediatrie.at/home/Spezialbereiche/Infektiologie/fieber_und_s...

25. XI. LA FIEVRE CHEZ L’ENFANT [Internet]. [zitiert 23. Mai 2018]. : http://www.pediatrie.be/fr/xi-la-fievre-chez-l_enfant/251/2

26. The College of Family Physicians Canada. Fever in Infants and Children [Internet]. 2011 [zitiert 23. Mai 2018].: http://www.cfpc.ca/ProjectAssets/Templates/Resource.aspx?id=3596

27. SOCHIPE - Soc. Chilena de Pediatría. Fiebre: Tratamiento Ambulatorio [Internet]. 2013 [zitiert 23. Mai 2018]. : http://www.sochipe.cl/v3/presenta_dos.php?id=610

28. Asociación de Pediatría de El Salvador. LO QUE DEBE SABER SOBRE LA FIEBRE DE SU HIJO [Internet]. ASOPEDES. 2015 [zitiert 23. Mai 2018]. : http://asopedes.org/lo-que-debe-saber-sobre-la-fiebre-de-su-hijo/

29. Agence française de sécurité sanitaire des produits de santé  (Afssaps). Mise au Point Sur la Prise en Charge de la Fievre Chez l’Enfant [Internet]. : http://ansm.sante.fr/var/ansm_site/storage/original/application/8a3e72e8...

30. Oteman N, Berger MY, Boomsma LJ, Wiersma TJ, Goudswaard AN, Nederlands Huisartsen Genootschap. [Summary of the practice guideline „Children with fever“ (Second Revision) from the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd. 20. Dezember 2008;152(51–52):2781–6. 

31. Green R, Jeena P, Kotze S, Lewis H, Webb D, Wells M, u. a. Management of acute fever in children: guideline for community healthcare providers and pharmacists. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 3. September 2013;103(12):948–54. 

32. Jehangir Apollo hospital. Fever in children [Internet]. 2013.: http://www.jehangirhospital.com/blog/item/2-fever-in-children

33. 1177 Vårdguiden. Fever in children/Feber hos barn – engelska - sjukdomar, undersökningar, hitta vård, e-tjänster [Internet]. [zitiert 23. Mai 2018]. : https://www.1177.se/Other-languages/Engelska/Barn/Feber--vad-kan-man-gor...

34. Swiss Pediatrics Association. When children are ill: some advice for parents [Internet]. 1995. : http://www.swiss-paediatrics.org/sites/default/files/parents/10-16_ans/m...

35. Asssociation of Ukranian Pediatricians. Fever and Hyperperexia In Children [Internet]. : http://www.uf.ua/wp-content/uploads/2017/05/Georgiyants_Lyhomanka_giperp...

36. National Institute for Health and Care Excellence (NICE). Fever in under 5s: assessment and initial management | Guidance and guidelines | NICE [Internet]. 2017 [zitiert 23. Mai 2018]. : https://www.nice.org.uk/guidance/cg160

37. Shann F, Mackenzie A. Comparison of Rectal, Axillary, and Forehead Temperatures. Arch Pediatr Adolesc Med. 1. Januar 1996;150(1):74–8. 

38. Matsukawa T, Sessler DI, Ozaki M, Hanagata K, Iwashita H, Kumazawa T. Comparison of distal oesophageal temperature with “deep” and tracheal temperatures. Can J Anaesth. April 1997;44(4):433–8. 

39. Tamura T, Huang M, Togawa T. Current Developments in Wearable Thermometers. Adv Biomed Eng. 2018;7:88–99. 

40. Offringa M, Newton R, Cozijnsen MA, Nevitt SJ. Prophylactic drug management for febrile seizures in children. Cochrane Epilepsy Group, Herausgeber. Cochrane Database Syst Rev [Internet]. 22. Februar 2017 [zitiert 9. April 2018]; : http://doi.wiley.com/10.1002/14651858.CD003031.pub3

41. Strengell T, Uhari M, Tarkka R, Uusimaa J, Alen R, Lautala P, u. a. Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch Pediatr Adolesc Med. September 2009;163(9):799–804. 

42. Rosenbloom E, Finkelstein Y, Adams-Webber T, Kozer E. Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis. Eur J Paediatr Neurol. November 2013;17(6):585–8. 

43. Martin DD. Fever: Views in Anthroposophic Medicine and their Scientific Validity. Evid Based Complement Alternat Med. 2016;2016(1):13 pages. 

44. Rouhani S, Meloney L, Ahn R, Nelson BD, Burke TF. Alternative Rehydration Methods: A Systematic Literature Review and Lessons for Resource-Limited Care. Pediatrics. 14. Februar 2011;peds.2010-0952. 

45. Nelson BD, Collins LB, Pritchard EWJ. Innovations in Low- and Middle-Income Countries for Newborn and Child Health. In: Innovating for Healthy Urbanization [Internet]. Springer, Boston, MA; 2015 [zitiert 23. Mai 2018]. S. 19–40. : https://link.springer.com/chapter/10.1007/978-1-4899-7597-3_2

46. Richardson M, Purssell E. Who’s afraid of fever? Arch Dis Child. September 2015;100(9):818–20. 

47. Plaisance KI, Mackowiak PA. Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med. 28. Februar 2000;160(4):449–56. 

48. Kiekkas P, Velissaris D, Karanikolas M, Aretha D, Samios A, Skartsani C, u. a. Peak body temperature predicts mortality in critically ill patients without cerebral damage. Heart Lung J Crit Care. Juni 2010;39(3):208–16. 

49. Wong VK, Hitchcock W, Mason WH. Meningococcal infections in children: a review of 100 cases. Pediatr Infect Dis J. April 1989;8(4):224–7. 

50. Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009;25(9):2207–2222. 

51. Souyri C, Olivier P, Grolleau S, Lapeyre-Mestre M. Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol. 2008;33(3):249–255. 

52. Ford LM, Waksman J. Necrotizing fasciitis during primary varicella. Pediatrics. 2000;105(6):1372–1375. 

53. Veenstra RP, Manson WE, van der Werf TS, Fijen J, Tulleken JE, Zijlstra JG, u. a. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. Intensive Care Med. 2001;27(11):1831–1831. 

54. Hidalgo-Carballal A, Suárez-Mier MP. Sudden unexpected death in a child with varicella caused by necrotizing fasciitis and streptococcal toxic shock syndrome. Am J Forensic Med Pathol. 2006;27(1):93–96. 

55. Weng T-C, Chen C-C, Toh H-S, Tang H-J. Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect. 2011;44(6):418–423. 

56. Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, u. a. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34(4):434–440. 

57. François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr. 2010;99(6):861–866. 

58. Elemraid MA, Thomas MF, Blain AP, Rushton SP, Spencer DA, Gennery AR, u. a. Risk factors for the development of pleural empyema in children. Pediatr Pulmonol. 2015;50(7):721–726. 

59. Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, Brémont F, u. a. Nonsteroidal anti-inflammatory drug without antibiotics for acute viral infection increases the empyema risk in children: A matched case-control study. J Pediatr. 2016;175:47–53. 

60. Voiriot G, Dury S, Parrot A, Mayaud C, Fartoukh M. Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. CHEST J. 2011;139(2):387–394. 

61. Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol. 2008;65(2):203–209. 

62. Beasley R, Clayton T, Crane J, von Mutius E, Lai CK., Montefort S, u. a. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. The Lancet. 2008;372(9643):1039–48. 

63. Etminan M, Sadatsafavi M, Jafari S, Doyle-Waters M, Aminzadeh K, FitzGerald JM. Acetaminophen Use and the Risk of Asthma in Children and Adults. Chest. 2009;136(5):1316. 

64. Perzanowski MS, Miller RL, Tang D, Ali D, Garfinkel RS, Chew GL, u. a. Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. Thorax. 2010;65(2):118. 

65. Kanabar D, Dale S, Rawat M. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms. Clin Ther. Dezember 2007;29(12):2716–23. 

66. Ludvigsson JF. Epidemiological study of constipation and other gastrointestinal symptoms in 8000 children. Acta Paediatr. 2006;95(5):573–580. 

67. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. Jama. 1995;273(12):929–933. 

68. Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. Juni 2006;15(6):398–405. 

69. Kang LW, Kidon MI, Chin CW, Hoon LS, Hwee CY, Chong NK. Severe anaphylactic reaction to ibuprofen in a child with recurrent urticaria. Pediatrics. 2007;120(3):e742–e744. 

70. Bachmeyer C, Vermeulen C, Habki R, Blay F, Leynadier F. Acetaminophen (paracetamol)-induced anaphylactic shock. South Med J. 2002;95(7):759–761. 

71. Jain SS, Green S, Rose M. Anaphylaxis following intravenous paracetamol: the problem is the solution. Anaesth Intensive Care. 2015;43(6). 

72. Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. Dezember 1990;162(6):1277–82. 

73. Husseini RH, Sweet C, Collie MH, Smith H. Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. J Infect Dis. April 1982;145(4):520–4. 

74. Earn DJ, Andrews PW, Bolker BM. Population-level effects of suppressing fever. Proc R Soc Lond B Biol Sci. 2014;281(1778):20132570. 

75. Huseman F. Scharlach und eitrige Angina in zehn Jahren Praxis. Merkurstab. 1998;51(1):16–24. 

76. Soldner G, Stellman HM. Krankheitsbekämpfung und Gesundheitsentwicklung: Therapiemöglichkeiten der Pneumonie im Kindesalter. Merkurstab. 2002;55:43–9. 

77. Harmsen IA, Ruiter RAC, Paulussen TGW, Mollema L, Kok G, de Melker HE. Factors that Influence Vaccination Decision-Making by Parents Who Visit an Anthroposophical Child Welfare Center: A Focus Group Study. Adv Prev Med. 2012;2012. 

78. Soldner G, Stellman HM. Individual Paediatrics: Physical, Emotional and Spiritual Aspects of Diagnosis and Counseling, Fourth edition. 4 edition. CRC Press; 2014.

79. Girke M. Innere Medizin. Grundlagen und therapeutische Konzepte der Anthroposophischen. Second Edition. Berlin: Salumed; 2012. 

80. Vagedes J, Soldner G. Das Kinder-Gesundheitsbuch. Gräfe und Unzer; 2008. 

81. Glöckler M, Goebel W. A Guide to Child Health: A Holistic Approach to Raising Healthy Children. Floris Books; 2013. 

82. Hamre HJ, Glockmann A, Schwarz R, Riley DS, Baars EW, Kiene H, u. a. Antibiotic use in children with acute respiratory or ear infections: prospective observational comparison of anthroposophic and conventional treatment under routine primary care conditions. Evid Based Complement Alternat Med. 2014;2014(Article ID 243801). 

83. Kummer KR. 1001mal Masern-prospektive Untersuchung von 886 und retrospektive von 115 Verläufen in der Praxis. Merkurstab. 1999;52:369–375. 

84. Fintelmann V, Hopferwieser M, Kennyeres B, Görnitz S. Die Masernepidemie in Salzburg, Ostern 2008. Merkurstab. 2011;64:128–42. 

85. Busche P. Masern im Erwachsenenalter – eine Kasuistik [Measles in Adulthood – a case report]. Merkurstab. 2015;68(6):455–8. 

86. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. The Lancet. 1999;353(9163):1485–8. 

87. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet. 1. Mai 1999;353(9163):1485–8. 

88. von Schoen-Angerer T, Wilkens J, Kienle GS, Kiene H, Vagedes J. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series. Perm J. 2015;19(4):76–83. 

89. Albonico HU, Bräker HU, Hüsler J. Febrile infectious childhood diseases in the history of cancer patients and matched controls. Med Hypotheses. Oktober 1998;51(4):315–20. 

90. Sutton LP, Dodge KG. The treatment of chorea by induced fever. J Pediatr. 1933;3(6):813–826. 

91. Sutton LP, Dodge KG. Fever therapy in chorea and in rheumatic carditis with and without chorea. J Lab Clin Med. 1936;21(6):619–628. 

92. Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, u. a. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J Virol. 2009;83(11):5890–5903. 

93. Baudouin SV, Saunders D, Tiangyou W, Elson JL, Poynter J, Pyle A, u. a. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet Lond Engl. 17. Dezember 2005;366(9503):2118–21. 

94. Young P, Saxena M, Bellomo R, Freebairn R, Hammond N, van Haren F, u. a. Acetaminophen for Fever in Critically Ill Patients with Suspected Infection. N Engl J Med. 2015;373(23):2215–2224. 

95. Williams LK, Peterson EL, Ownby DR, Johnson CC. The relationship between early fever and allergic sensitization at age 6 to 7 years. J Allergy Clin Immunol. Februar 2004;113(2):291–6. 

96. Williams LK, Peterson EL, Pladevall M, Tunceli K, Ownby DR, Johnson CC. Timing and intensity of early fevers and the development of allergies and asthma. J Allergy Clin Immunol. Juli 2005;116(1):102–8. 

97. von Mutius E, Illi S, Hirsch T, Leupold W, Keil U, Weiland S. Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children. Eur Respir J. 1. Juli 1999;14(1):4–11. 

98. Matricardi PM, Franzinelli F, Franco A, Caprio G, Murru F, Cioffi D, u. a. Sibship size, birth order, and atopy in 11,371 Italian young men. J Allergy Clin Immunol. 1998;101(4):439–44. 

99. Curran LK, Newschaffer CJ, Lee L-C, Crawford SO, Johnston MV, Zimmerman AW. Behaviors Associated With Fever in Children With Autism Spectrum Disorders. PEDIATRICS. Dezember 2007;120(6):e1386–92. 

100. Mehler MF, Purpura DP. Autism, fever, epigenetics and the locus coeruleus. Brain Res Rev. 2009;59(2):388–92. 

101. Grossarth-Maticek R, Frentzel-Beyme R, Kanazir D, Jankovic M, Vetter H. Reported herpes-virus-infection, fever and cancer incidence in a prospective study. J Chronic Dis. 1987;40(10):967–76. 

102. Wrotek S, Kamecki K, Kwiatkowski S, Kozak W. Cancer patients report a history of fewer fevers during infections than healthy controls. J Pre-Clin Clin Res. 2009;3(1):031–5. 

103. Kölmel KF, Pfahlberg A, Mastrangelo G, Niin M, Botev I, Seebacher C, u. a. Infections and melanoma risk: results of a multicentre EORTC case-control study. Melanoma Res. 1999;9(5):511. 

104. Krone B, Kölmel K, Grange J, Mastrangelo G, Henz B, Botev I, u. a. Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. Eur J Cancer. 2003;39(16):2372–8. 

105. Kokolus KM, Capitano ML, Lee C-T, Eng JW-L, Waight JD, Hylander BL, u. a. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci. 2013;110(50):20176–20181. 

106. Coley WB. The Treatment of Sarcoma of the Long Bones. Ann Surg. March 1933;97(3):434–60. 

107. Kienle GS. Fever in cancer treatment: Coley’s therapy and epidemiologic observations. Glob Adv Health Med. 2012;1(1):92–100. 

108. Coussens LM, Werb Z. Inflammation and cancer. Nature. 19. Dezember 2002;420(6917):860–7. 

109. Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother. 2001;50(8):391–6. 

110. Kleef R, Jonas WB, Knogler W, Stenzinger W. Fever, cancer incidence and spontaneous remissions. Neuroimmunomodulation. 2000;9(2):55–64. 

111. Hobohm U. Fever therapy revisited. Br J Cancer. 2005;92(3):421–5. 

112. Levin JS. Spontaneous Remission: An Annotated Bibliography. JSTOR; 1995. 

113. Hager ED. Fever, Pyrogens and Cancer. Eurekah Biosci. 2005;1(8):680–710. 

114. Abdelrazeq AS. Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005. Int J Colorectal Dis. 2007;22(7):727–36. 

115. Madeleyn R, Soldner G, Tautz C, von Laue B. Hirntumore bei Kindern: Therapieverläufe/Teil II. Merkurstab. 2002;1/2002:36–47. 

116. Richardson M, Purssell E. Who’s afraid of fever? Arch Dis Child. 2015;100(9):818–820. 

117. Mouihate A, Harré E-M, Martin S, Pittman QJ. Suppression of the Febrile Response in Late Gestation: Evidence, Mechanisms and Outcomes. J Neuroendocrinol. April 2008;20(4):508–14. 

118. Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, u. a. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2012;185(10):1088–1095. 

119. Shime N, Hosokawa K, MacLaren G. Does cooling really improve outcomes in patients with septic shock? Am J Respir Crit Care Med. 2013;187(11):1274–1275. 

120. Thoresen M. Who should we cool after perinatal asphyxia? In: Seminars in Fetal and Neonatal Medicine [Internet]. Elsevier; 2015 [zitiert 28. Mai 2016]. S. 66–71. http://www.sciencedirect.com/science/article/pii/S1744165X15000153

121. Ghandi Y, Chaichi PY, Sharifi M, Bolandnazar N, others. The Brugada Syndrome Unmasked by Fever in a Two-Year-Old Child: Case Report. J Compr Pediatr. 2016;7(1). 

122. Probst V, Denjoy I, Meregalli PG, Amirault J-C, Sacher F, Mansourati J, u. a. Clinical aspects and prognosis of Brugada syndrome in children. Circulation. 2007;115(15):2042–2048. 

123. A Nemzeti Erőforrás Minisztérium szakmai protokollja, Lázas gyermekek ellátásáról. http://www.kozlonyok.hu/kozlonyok/kozlonyok/6/pdf/2011/7.pdf. 2011/07;1311–1317.

124. Mikos B. et al., Az antibiotikus terápia múltja, jelene és jövője. Gyermekgyógyászat. 2019; 70(1.): 32–37.

125. Bert Holldobler & Edward O. Wilson: The Ants, 1990,  p. 373

126. Mohammed, R.S., Reynolds, M., James, J. et al. Oecologia (2016) 181: 911. https://doi.org/10.1007/s00442-016-3598-1

127. https://hu.wikibooks.org/w/index.php?title=Jegyzetek_medikusoknak/Klinik...ógia/A_láz&oldid=322382

128. https://weborvos.hu/adat/magyarorvos/maj/38-40.pdf

129. Szakács J.: A hőháztartás zavarai, SE jegyzet, 2010

130. D. Counts, M. Acosta, H. Holbrook, E. Foos, K. Hays-Ponder, O. Macairan, L. Thomas, M. Whitsett, L. Williams, E. J. Twiss (2014) Evaluation of temporal artery and disposable digital oral thermometers in acutely ill patients, RESEARCH FOR PRACTICE, 23(4):239-250

131. Hiller Barbara Láz, lázcsillapítás – az ápolók ismeretei és a hazai gyakorlat, PTE ETK szakdolgozat, 2017

132. Martin D. Fieberkrämpfe: Hilft Wärme im Fieberanstieg? Zeitschrift für Komplementärmedizin. 2017;9(01):38–41.

133. Harden LM, Kent S, Pittman QJ, Roth J. Fever and sickness behavior: Friend or foe? Brain, Behavior, and Immunity. 2015;50:322–333.

134. Mouihate A, Harré E-M, Martin S, Pittman QJ. Suppression of the Febrile Response in Late Gestation: Evidence, Mechanisms and Outcomes. J Neuroendocrinol. 2008 Apr;20(4):508–14.

135. Vásárhelyi B. http://medicalonline.hu/haziorvostan/cikk/a_gyulladas_es_a_laborvizsgalatok, 06. 26. 2015.

136. Ulbricht M. Antipyretische Wirkung eines körperwarmen Einlaufes. Inaugurierungsdissertation, Universität Tübingen; 1991.

137. https://upload.wikimedia.org/wikipedia/hu/d/db/Hőtermelés.png

138. Wysocki J. et al., A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations. Vaccine. 2017 Apr 4;35(15):1926-1935. doi: 10.1016/j.vaccine.2017.02.035. Epub 2017 Mar 3.

139. Prymula R. et al., Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials, Lancet. 2009 Oct 17;374(9698):1339-50. doi: 10.1016/S0140-6736(09)61208-3.

140. Doedée AM. et al., Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials. PLoS One. 2014 Jun 4;9(6):e98175. doi: 10.1371/journal.pone.0098175. eCollection 2014.

141. Carazo Perez S., Bureau A., De Serres G., Post-immunisation fever and the antibody response to measlescontaining vaccines. Epidemiol Infect. 2018 Jun 11:1-9. doi: 10.1017/S0950268818001474.

142. Sil A. et al.,  Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants, Vaccine. 2017 May 19;35(22):2999-3006. doi: 10.1016/j.vaccine.2017.03.009. Epub 2017 Apr 24.

143. Walter EB., The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children. Vaccine. 2017 Dec 4;35(48 Pt B):6664-6671. doi: 10.1016/j.vaccine.2017.10.020. Epub 2017 Oct 19.

144. Murdoch H., Risk of hospitalisation with fever following MenB vaccination: selfcontrolled case series analysis. Arch Dis Child. 2017 Oct;102(10):894-898. doi: 10.1136/archdischild-2017-313079

145. Kádár J., http://immunkozpont.hu

146. Magyar T., A felsőlégúti infekciók antibiotikum terápiája, https://weborvos.hu/granum/a-felsoleguti-infekciok-antibiotikum-terapiaj...

147. Trippella G., Ciarcià M., de Martino M., Chiappini E., Prescribing Controversies: An Updated Review and Meta-Analysis on Combined/Alternating Use of Ibuprofen and Paracetamol in Febrile Children, Frontiers in Pediatrics, June 2019 | Volume 7 | Article 217

148. Chang  Dong Lin et al., Fever Promotes T Lymphocyte Trafficking via a Thermal Sensory Pathway Involving Heat Shock Protein 90 and α4 Integrins, Immunity, VOLUME 50, ISSUE 1, P137-151.E6, JANUARY 15, 2019, DOI:https://doi.org/10.1016/j.immuni.2018.11.013

149. Sharon S. Evans, Elizabeth A. Repasky, Daniel T. Fisher, Fever and the thermal regulation of immunity: the immune system feels the heat, Nature Reviews Immunology, 2015 volume15, pages 335–349

150. Matthew J. et al., Role of Fever in Disease, Annals of the New York Academy of Sciences, First published: 07 February 2006 https://doi.org/10.1111/j.1749-6632.1998.tb08329

151. Falup-Pecurariu O. et al., Effects of prophylactic ibuprofen and paracetamol administration on the immunogenicity and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugated vaccine (PHiD-CV) co-administered with DTPa-combined vaccines in children: An open-label, randomized, controlled, non-inferiority trial, Hum Vaccin Immunother. 2017 Mar; 13(3): 649–660. Published online 2016 Aug 19. doi: 10.1080/21645515.2016.1223001

152. Erin L. Sauer, Nadia Trejo, Jason T. Hoverman,  Jason R. Rohr, Behavioural fever reduces ranaviral infection in toads, Functional Ecology, First published: 02 August 2019, https://doi.org/10.1111/1365-2435.13427

153. Boltana S, Rey S, Roher N, Vargas R, Huerta M, Huntingford FA, Goetz FW, Moore J, Garcia-Valtanen P, Estepa A, MacKenzie S., Behavioural fever is a synergic signal amplifying the innate immune response. Proc R Soc B 2013, 280: 20131381. http://dx.doi.org/10.1098/rspb.2013.1381

154. NICE guideline, Fever in under 5s: assessment and initial management, Published: 7 November 2019, www.nice.org.uk/guidance/ng143

155. Carrie Daymont et al.: Heart Rates in Hospitalized Children by Age and Body Temperature, PEDIATRICS Volume 135, number 5, May 2015, https://pediatrics.aappublications.org/content/135/5/e1173

156. R G Nijman et al.: Derivation and validation of age and temperature specific reference values and centile charts to predict lower respiratory tract infection in children with fever: prospective observational study, BMJ 2012; 345:e4224https://www.bmj.com/content/345/bmj.e4224, doi: https://doi.org/10.1136/bmj.e4224

157. Andrew J Brent, et al.: Risk score to stratify children with suspected serious bacterial infection: observational cohort study, Arch Dis Child 2011;96:361–367. doi:10.1136/adc.2010.183111

158. Andrew J Brent, et al.: Evaluation of temperature–pulse centile charts in identifying serious bacterial illness: observational cohort studyArch Dis Child 2011;96:368–373. doi:10.1136/adc.2010.183129

159. Susannah Fleming et al.: Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies, The Lancet, VOLUME 377, ISSUE 9770, P1011-1018, MARCH 19, 2011, https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)62226-X/fulltext

160. Paul J Young, Rinaldo Bellomo: Fever in sepsis: is it cool to be hot?, Crit Care. 2014; 18(1): 109., Published online 2014 Feb 13. doi: 10.1186/cc13726, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056432/

161. Lei Fang, George Karakiulakis, Michael Roth: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med 2020, Published Online March 11, 2020, https://www.thelancet.com/…/la…/PIIS2213-2600(20)30116-8.pdf

162.  https://www.pharmaco-vigilance.eu/content/nsaids-pneumonia-and-empyema-ongoing-confrontation?fbclid=IwAR0Vx1eyKsWShB4w2OrRihwfGA0h6bclfB0xnl0zGB8mF-s6lfuSXoKJfog

163.  https://www.ncbi.nlm.nih.gov/pubmed/28005149?fbclid=IwAR1VOY8sDkm9h9TEcU8NIr2a0JxrkvHGKF8HTZku9kRHusAigLhs8zLfExU

164. https://www.ebm-netzwerk.de/de/veroeffentlichungen/covid-19

165. https://www.nhs.uk/conditions/fever-in-children/

166. https://www.crick.ac.uk/news/2019-07-02_antibiotics-weaken-flu-defences-in-the-lung

167. https://www.thelancet.com/action/showPdf?pii=S1473-3099%2820%2930198-5

168. Chaomin Wu et al.: Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med. doi:10.1001/jamainternmed.2020.0994, Published online March 13, 2020.